Trouble reading this email? View it in your browser
European Federation of Pharmaceutical industries and associations

EFPIA Newsletter 5 May 2022


Why does pharmaceutical innovation in Europe matter for jobs and growth?

Lars Fruergaard Jørgensen (Novo Nordisk) for POLITICO

Recent crises have highlighted the critical need for Europe to secure and strengthen its position as leader in medical innovation. As the European Commission works on the next Pharmaceutical Strategy, we need to ensure Europe has the right environment to bring the next generation of treatments to patients. The challenge for the coming decades is not if medical innovation will happen but where it will happen. This article is part of a series explaining that where innovation happens matters for patients, health care systems, the research community, jobs and the economy.

Read more




EFPIA statement on the legislative proposal on the European Health Data Space (EHDS)
05 May 2022

Removing the barriers to health data for scientific research will mean patients can benefit from the discovery of innovative... Read more

Roberta Savli appointed as Executive Director of Public Affairs at EFPIA
02 May 2022

Roberta will take on the new role with immediate effect. Read more

EFPIA statement on the EU-Turkey WTO Case on Pharmaceuticals
29 April 2022

EFPIA Members stand ready to work closely with the Government of Turkey with a view to continue to build an ecosystem... Read more




Innovative Medicines for Luxembourg (IML) - Connecting the dots to enhance the innovation ecosystem...
05 May 2022 - Sini Eskola - Magda Chlebus

IML is EFPIA's newest member association Read more

Should we revise our definition of “patient access”? (Guest blog)
04 May 2022 - Luca Morlotti

Patient access to new treatments is my personal goal. But it will always be joint effort. Read more


Regulatory Road to Innovation

Watch our expert's video interviews and learn more on


How to future-proof the EU regulatory framework?
Alan Morrison, EFPIA RSC Chair & VP RA International, MSD Read more

How can we make the regulatory decision-making process more agile?
Emma Du Four, Head of International Regulatory Policy and Intelligence, AbbVie Read more




Towards a new normal: Why boosting cardiovascular health is critical
13 May 2022 (Virtual event)

Opportunities for healthcare systems to build back better for patients in Europe Read more

Maximise EHDS impact on better health data sharing
18 May 2022 (Hybrid in Brussels (Rue de l’Industrie 24, 1040 Brussels) and Online)

European Health Coalition Hybrid Workshop on the new European Health Data Space Proposal Read more

Faster, more equitable access to medicines across Europe
19 May 2022 (Virtual event)

How pharma and healthcare stakeholders can find collaborative solutions Read more

Future Clinical Trials conference – from tomorrow to 2030 – Why choose the Nordics?
07 June 2022 (in Helsinki or virtually)

The event will take place in Team Finland House (Porkkalankatu 1, Helsinki). It is also possible to follow the event... Read more


What we are reading


Pharma industry improved since before pandemic say patient groups
On 03 May 2022 (Euractiv)

Since the pandemic, the public image of big pharma companies such as Sanofi, Pfizer, AstraZeneca, and Bayer has improved,... Read more

Europe’s push to rival US biotech hubs faces hit from market slump
On 26 April 2022 (Financial Times)

“We do have the science, technology and innovation in Europe, we just don’t seem to be quite as good at funding it.”... Read more

Dream Big, Vaccines Protect Us
On 25 April 2022 (Sanofi)

For over 100 years, Sanofi vaccines have been protecting the health of millions. Read more